Advertising
Advertising
twitter
youtube
facebook
instagram
linkedin
Advertising

Last recommendation BDM - – ESOTIQ&HENDERSON BUY with target price 39,2 PLN/share

Last recommendation BDM - – ESOTIQ&HENDERSON BUY with target price 39,2 PLN/share
Aa
Share
facebook
twitter
linkedin

Table of contents

  1. BDM's comments:
    1.  
    2. Explanation of ratings:
    3. Explanations of terminology:

 

last recommendation bdm esotiq henderson buy with target price 39 2 pln share grafika numer 1last recommendation bdm esotiq henderson buy with target price 39 2 pln share grafika numer 1

 

Last recommendation BDM: BUY with target price 39,2 PLN/share (2023/05/19) 

Q1'23 results below our expectations - cost growth continues to progress, but at a slower pace (slightly negative) Q1'23 was very successful for the company in terms of revenue (+20.3% y/y) and gross margin on sales (62.7% vs. 62.0% a year earlier). Internet sales did particularly well, reaching a record PLN 13.3 million, according to monthly sales data.

Advertising

 

At the level of operating expenses, Q1'22 represents a high base. It was the last quarter before a jump in sales costs, yet the company recorded a significant increase in operating profit (+54.2% y/y). The company is focusing on cost savings and improving profitability. Process automation and optimization projects have been implemented, which is expected to allow for increased efficiency without hiring additional personnel.

 

The company reduced inventory levels by about PLN 3 million q/q, which we view positively, given the high Q1 gross sales margin. The company's target for the whole of 2023 is to reduce inventory levels by several million PLN. The margin increase may be the result of a change in pricing policy - currently prices are stickered in the store, rather than at the production stage. This is expected to reduce foreign exchange risk and transportation costs.

 

BDM's comments:

The Q1'23 results turned out to be lower than our forecasts. This was mainly due to underestimation of selling expenses and increased costs of other operations. General and administrative expenses increased along with other operating income, so we expect this was due to higher the RFiD project expenses and subsidy.

Advertising

 

Net profit amounted to PLN 0.2 million, down -90.7% from the previous year. However, it should be remembered that in that period there was a gain on the disposal of own shares in the amount of about PLN 2.5 million, which significantly distorted the Q1'22 picture. We view the Q1'23 results slightly negatively - at the operating profit level, we expected larger increases relative to the same period in 2022.

 

Cost growth dynamics is slowing down, so we stand by our medium- and long-term assumptions described in our last recommendation (link). We note that Q1 has historically been the weakest period of the year for the company in terms of sales and one of the weaker in terms of margins.

 

last recommendation bdm esotiq henderson buy with target price 39 2 pln share grafika numer 2last recommendation bdm esotiq henderson buy with target price 39 2 pln share grafika numer 2

 

Advertising

 

Explanation of ratings:


Buy – we believe that the security will reach the target price in the recommended period, which significantly exceeds the current market price (at least + 15%);

Accumulate – we believe that the security will reach the target price in the recommended period, which exceeds the current market price (in the range of +5 to + 14.99%);

Hold – we believe that a security in the recommended period will fluctuate around the target price, which is close to the current market price (in the range from -4.99% to + 4.99%);

Reduce – we believe that the security will reach the target price in the recommended period, which is lower than the market price (range of decline from 5% to 14.99%);

Sell – we believe that a security in the recommended period will reach the target price, which is significantly lower than the market price (suggested erosion of the value exceeds 15%).

Advertising

Target price – the theoretical price which, in our opinion, should reach a security in the recommended period; This price is the result of the company's value (eg based on DCF, comparative and other valuations), market conditions and the industry as well as other factors subjectively considered by the analyst.

 

Recommendations made by BDM are binding for 12 months from the issue date or until the target level is reached, unless they are updated during this period of time.


last recommendation bdm esotiq henderson buy with target price 39 2 pln share grafika numer 3last recommendation bdm esotiq henderson buy with target price 39 2 pln share grafika numer 3

 

last recommendation bdm esotiq henderson buy with target price 39 2 pln share grafika numer 4last recommendation bdm esotiq henderson buy with target price 39 2 pln share grafika numer 4

 

Explanations of terminology:

Advertising


EBIT - earnings before interest and tax
EBITDA — earnings before interest, taxes, depreciation, and amortization
Net debt – interest bearing debt minus cash and equivalents
WACC - weighted average cost of capital
CAGR - cumulative average annual growth
EPS - earnings per share
DPS - dividend per share
CEPS - net profit plus depreciation per share
EV – market capitalization plus interest bearing debt minus cash and equivalents
EV/S – market capitalization / sales
EV/EBITDA – EV / sales
P/EBIT – market capitalization / EBIT
MC/S — market capitalization / sales
P/E — market capitalization / net profit
P/BV — market capitalization / book value
P/CE - market capitalization / net profit plus depreciation
ROE – net profit / equity
ROA - net income / assets
Gross margin - gross profit on sales / sales
EBITDA margin – EBITDA / sales
EBIT margin – EBIT / sales
Net margin – net profit / sales


GPW’s Analytical Coverage Support Programme 3.0

GPW’s Analytical Coverage Support Programme 3.0

The Warsaw Stock Exchange's (GPW's) Analytical Coverage Support Programme 3.0 supports investment firms in drafting analytical reports which are financed by GPW. The objective of the Programme is to improve the availability of research covering less liquid companies, facilitating investors' informed investment decisions based on a reliable independent source of issuer information. Eligible to participate in the Programme are companies listed on the GPW Main Market (other than WIG20 participants) and on NewConnect. The Programme covers up to 50 issuers.

Twitter | LinkedIn 


Advertising
Advertising